Ординатура / Офтальмология / Английские материалы / The Eye Book A Complete Guide to Eye Disorders and Health_Cassel, Billig, Randall_2001

570 / GENERAL INDEX

tear ducts, 7f, 354f, 355, 368 tear glands, 4, 7f, 145, 354f, 355,

358; and systemic disorders, 464, 467

tearing: basic, 355; excessive, 356, 361, 367–68; reflex, 355; tests of, 66, 72–73

tears, 4–5, 353–71; and AIDS, 472; antibacterial, 335; artificial, 334, 338, 360, 499, 534; and contact lenses, 127–28, 130–31, 138, 144–46, 151, 159; and cornea, 329, 337; as defense, 150, 345, 411; distribution of, 361–62; drainage of, 367–68; mucin layer in, 353, 354f, 359, 362–63, 364; quality of, 356, 357, 359–60; quantity of, 357–59; questions about, 369–71; and systemic disorders, 467, 469

Tears Naturale, 535

tear supplements, 149, 364–65, 369, 371; and computers, 114, 115; for systemic disorders, 468, 469

television, 115, 482

temporal arteritis, 78, 389, 402, 416–17, 445, 500

Tenormin, 498 Tensilon test, 470 Terra-Cortil, 523 Terramycin, 523 tetracaine, 508 Tetracon, 519

tetracycline, 359, 469, 475, 494 Thalidomide, 309

thimerosal, 153–54 thyroid disease, 45, 72, 158,

259, 358, 459, 464–68; NOSPECS classification of, 466–68

TIAs (transient ischemic attacks), 400, 449

Ticlid, 448 ticlopidine, 448

tight-lens syndrome, 151–53 timolol, 273, 526–27 Timoptic, 271–74, 527 TobraDex, 523

tobramycin, 512, 522 Tobrex, 513

tonometry, 472; applanation, 62f, 63, 257

toxoplasmosis, ocular, 473 trabecular meshwork, 12f; and

glaucoma, 247–54, 248f, 252f, 280; surgery on, 281–83, 284f

trabeculectomy, 283–86, 284f, 287

trabeculoplasty, laser, 281 trachoma, 359

transient ischemic attacks (TIAs), 444–45

transplants, corneal, 339, 340, 408

trifluridine, 514

trifocals, 82–83, 84f, 163, 239 trimethoprim, 522

tropicamide, 526 Trusopt, 278, 531

tumors, 75, 327–28, 376, 460, 462; in brain, 415; on eyelids, 313, 327–28; and headaches, 453, 459

ulcers, 373; corneal, 150, 334–36, 366, 453

ultrasound, 447, 467; in examinations, 75, 219; in surgery, 227, 241

ultraviolet (UV) light, 87, 240, 328, 350, 511; and cataracts, 200–1, 204; damage from, xix, 301, 302, 340–41

University of California

(Berkeley) School of Optometry, 164

Ureaphil, 533 uvea, 276, 372–77

uveitis, 325, 372–74, 383, 475

Vasoclear, 517

Vasocon, 517 Vasocon-A, 519 vasoconstrictors, 364

vasoproliferative factor, 427 venous beading, 424f, 426 vertex distance, 97, 100 Vexol, 517

Vira-A, 515

Viroptic, 515 viruses, 335, 398 Visine, 347, 519

GENERAL INDEX / 571

Visine LR, 517

vision, 18f, 21; binocular, 17, 37, 164, 237; and brain, 18, 37; central, 15, 415, 423; changes in, 41–48; development of, 110–11; intermediate, 113, 165; myths about, xviii–xxi, 115; near, 56, 58; residual, 476; 20/20, 46–47, 58. See also low vision

vision loss, 392–93, 394, 413–18, 468, 501; bilateral, 414, 461; and migraines, 413, 455–56, 457; unilateral, 414, 460–61. See also blindness

visual acuity, 78, 440; and cataract surgery, 209–10, 211, 236–37; and cones, 293, 294; and corrective lenses, 110–12, 118; damage to, 305, 397, 432; measurement of, 46–47, 56–58, 208–9, 304–5

visual disturbances, transient, 413–16

visual fields: disruptions in, 413; and glaucoma, 255–56, 262–63, 264f; loss of, 77–78, 290, 381, 387, 397, 413–15, 461; and low vision, 482; measurement of, 66–71, 67f, 262–65, 266, 320, 462; and medications, 502; and migraines, 455–56

vitamins, xx, 203–4, 301–3, 359 vitiligo, 373